Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 11, 2019 Off

Boehringer Ingelheim and University of Dundee Highlight Successful PROTAC Drug Discovery Program and Extend Their Ongoing Anti-Cancer Alliance

By BusinessWire

Boehringer Ingelheim and University of Dundee achieve milestone in collaboration aimed at developing novel protein degradation medicines Results published in…

June 11, 2019 Off

Agilent Companion Diagnostic Gains Expanded FDA Approval in Head and Neck Squamous Cell Carcinoma (HNSCC)

By BusinessWire

PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify HNSCC patients for treatment with KEYTRUDA® (pembrolizumab)…

June 11, 2019 Off

Aerie Pharmaceuticals to Present at Two Upcoming Investor Conferences

By BusinessWire

DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies…

June 11, 2019 Off

Genestack launches Omics Data Manager, an enterprise software solution to make omics data FAIR

By BusinessWire

CAMBRIDGE, England–(BUSINESS WIRE)–#FAIRdata–Genestack, a global player in life science R&D informatics, today announced the launch of Omics Data Manager, an…

June 11, 2019 Off

Kraig Biocraft Laboratories Management Travels to Vietnam to Oversee Prodigy Textiles Construction and Expansion

By BusinessWire

ANN ARBOR, Mich.–(BUSINESS WIRE)–$KBLB #KBLB–Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces…

June 11, 2019 Off

Deciphera Pharmaceuticals, Inc. and Zai Lab Limited Announce an Exclusive License Agreement for Ripretinib in Greater China

By BusinessWire

– Zai Lab to Lead the Development and Commercialization of Ripretinib in Greater China – – Deciphera To Receive $20…

June 11, 2019 Off

FDA Approves Two New Indications for Merck’s KEYTRUDA® (pembrolizumab)

By BusinessWire

KEYTRUDA Now Approved for First-Line Treatment of Patients with Metastatic or with Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma…

June 11, 2019 Off

AlloVir Announces Viralym-M Granted Regenerative Medicine Advanced Therapy (RMAT) Designation for the Treatment of Hemorrhagic Cystitis Caused by BK Virus in Adults and Children Following Allogeneic HSCT

By BusinessWire

RMAT designation follows positive Phase 2 proof-of-concept data published in the Journal of Clinical Oncology (JCO) for Viralym-M, an allogeneic,…

June 11, 2019 Off

Global Genetic Disorders Partnering Directory 2014-2019 – Comprehensive Access to 350+ Deal Records – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Genetic Disorders Partnering 2014-2019: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering. Global…

June 11, 2019 Off

TrialAssure launches TrialResults.com for Clinical Trial Sponsors to Publicly Post Plain Language Summaries

By BusinessWire

TrialResults.com helps lead the way in assisting clinical trial sponsors to #BeTransparent AMSTERDAM & CANTON, Mich.–(BUSINESS WIRE)–#BeTransparent–TrialAssure® – a leading,…

Posts pagination

Previous 1 … 3,107 3,108 3,109 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine